Sign up to save your podcasts
Or
Share Unlocking value for the patient in the consumer genomics market - a conversation with Robin Thurston
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Unlocking value for the patient in the consumer genomics market - a conversation with Robin Thurston
Today's Guest: Robin Thurston | CEO of Helix
Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers.
Important links:
Helix Web Site: http://helix.com Helix' DNA Product Studio: https://www.prnewswire.com/news-releases/helix-announces-dna-product-studio-to-power-rapid-development-of-new-genomics-apps-and-tests-300733874.html Robin's LinkedIn: https://www.linkedin.com/in/robinthurston/ Robin on Twitter: https://twitter.com/RobinJThurston
For more info about Greg Matthews, visit: http://linkedin.com/in/gdmatthews
For more, visit the DataPoint show page at http://touchpoint.health/shows/datapoint/.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By touch point media
5
4444 ratings
Today's Guest: Robin Thurston | CEO of Helix
Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers.
Important links:
Helix Web Site: http://helix.com Helix' DNA Product Studio: https://www.prnewswire.com/news-releases/helix-announces-dna-product-studio-to-power-rapid-development-of-new-genomics-apps-and-tests-300733874.html Robin's LinkedIn: https://www.linkedin.com/in/robinthurston/ Robin on Twitter: https://twitter.com/RobinJThurston
For more info about Greg Matthews, visit: http://linkedin.com/in/gdmatthews
For more, visit the DataPoint show page at http://touchpoint.health/shows/datapoint/.
Learn more about your ad choices. Visit megaphone.fm/adchoices